MacroPore Biosurgery, Inc.
Regenerative medicine company receives $11 million from equity placement
Published in Cardiovascular Business Week, June 28th, 2005
MacroPore will use these funds primarily to support the research and development of its regenerative cell technology.
MacroPore Biosurgery specializes in the discovery and development of regenerative medicine therapies. The company has 2 principal technology platforms, adipose-derived regenerative cells and bioresorbable implants.
The company is developing treatments for cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- SIH Telemedicine
Israel-based telemedicine systems developer reports Q1 2005 results, contracts - Sophion Bioscience A/S
Danish producer of patch clamping devices reports on sales, marketing, growth - Sorin Group
Developer of technologies or cardiac surgery reports on stockholders meeting - The LEO Pharma Research Foundation
Malignant ascites researcher receives grant - Abaxis, Inc.
Company releases Lipid Panel Plus - ACT NOW
Telemedicine, 'stroke box' initiatives get help to acute stroke victims quickly - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
